<- Go Home

Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Market Cap

$25.5M

Volume

57.9K

Cash and Equivalents

$1.2M

EBITDA

-$8.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$74.0K

Profit Margin

100.00%

52 Week High

$9.00

52 Week Low

$2.74

Dividend

N/A

Price / Book Value

9.16

Price / Earnings

-12.83

Price / Tangible Book Value

15.25

Enterprise Value

$24.3M

Enterprise Value / EBITDA

-2.97

Operating Income

-$8.2M

Return on Equity

832.21%

Return on Assets

-162.14

Cash and Short Term Investments

$1.2M

Debt

N/A

Equity

$2.8M

Revenue

$74.0K

Unlevered FCF

-$3.8M

Sector

Health Care Technology

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches